0001209191-20-009048.txt : 20200213 0001209191-20-009048.hdr.sgml : 20200213 20200213070306 ACCESSION NUMBER: 0001209191-20-009048 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200211 FILED AS OF DATE: 20200213 DATE AS OF CHANGE: 20200213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Drape Eric CENTRAL INDEX KEY: 0001790905 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16174 FILM NUMBER: 20606895 MAIL ADDRESS: STREET 1: C/O TEVA, 5 BASEL STREET, P.O. BOX 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 4951033 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TEVA PHARMACEUTICAL INDUSTRIES LTD CENTRAL INDEX KEY: 0000818686 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 BAZEL ST STREET 2: P O B 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 49131 BUSINESS PHONE: 9729267267 MAIL ADDRESS: STREET 1: TEVA PHARMACEUTICAL INDUSTRIES LIMITED STREET 2: 5 BAZEL ST PO B 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 49131 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-11 0 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0001790905 Drape Eric C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 5 BASEL STREET PETACH TIKVA L3 4951033 ISRAEL 0 1 0 0 Executive VP Global Operations Restricted Share Units 2020-02-11 4 A 0 13090 0.00 A Ordinary Shares 13090 13090 D Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on February 14, 2020. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Dov Bergwerk as attorney-in-fact for Eric Drape 2020-02-13